Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines is a research paper published in Human Mutation (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Institut National Du Cancer
Grant: 1R01CA242218‐01
National Health and Medical Research Council
Grant: ID1061779
National Health and Medical Research Council
Grant: ID1177524
National Institute for Health Research (NIHR)
Grant: IS-BRC-1215-20007
Intramural NIH HHS
Grant: ZIA CP010144
NCI NIH HHS
Grant: R01 CA242218
University of Queensland
MeSH Terms
Keywords